About PRAHA VACCINES
PRAHA VACCINES is a company based in Kutna Hora (Czechia) founded in 2017 was acquired by Novavax in May 2020.. The company has 4,148 employees as of December 31, 2021. PRAHA VACCINES operates in a competitive market with competitors including Neovacs, Intravacc, Fina Biosolutions, Yapanbio and VERAXA, among others.
- Headquarter Kutna Hora, Czechia
- Employees 4148 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Active 24, S.R.O.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of PRAHA VACCINES
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PRAHA VACCINES
PRAHA VACCINES has secured backing from 1 investor. Prominent investors backing the company include Novavax. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Novel vaccines are developed using nanoparticle and matrix adjuvant technology.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PRAHA VACCINES
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PRAHA VACCINES
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Praha Vaccines Comparisons
Competitors of PRAHA VACCINES
PRAHA VACCINES operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neovacs, Intravacc, Fina Biosolutions, Yapanbio and VERAXA, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vaccine manufacturing services are provided by Neovacs CDMO.
|
|
| domain | founded_year | HQ Location |
Vaccine development services for bacterial and viral vaccines are provided.
|
|
| domain | founded_year | HQ Location |
Biotechnology company specializing in bioconjugation services mainly for vaccine development
|
|
| domain | founded_year | HQ Location |
Contract manufacturing of bio-therapeutics and vaccines is provided.
|
|
| domain | founded_year | HQ Location |
Antibody therapeutics for cancer treatment are developed via microfluidic screening.
|
|
| domain | founded_year | HQ Location |
New molecules are discovered, developed, and manufactured in biotechnology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Praha Vaccines
Frequently Asked Questions about PRAHA VACCINES
When was PRAHA VACCINES founded?
PRAHA VACCINES was founded in 2017.
Where is PRAHA VACCINES located?
PRAHA VACCINES is headquartered in Kutna Hora, Czechia. It is registered at Kutna Hora, Central Bohemian Region, Czechia.
How many employees does PRAHA VACCINES have?
As of Dec 31, 2021, the latest employee count at PRAHA VACCINES is 4,148.
What is the annual revenue of PRAHA VACCINES?
Annual revenue of PRAHA VACCINES is $8.29M as on Dec 31, 2022.
What does PRAHA VACCINES do?
PRAHA VACCINES was established in 2017 in Kutna Hora, Czech Republic. Operations are centered on the development and production of serums and vaccines within the biotechnology and pharmaceutical sectors. Research activities are conducted to support vaccine manufacturing, with a focus on serum-based solutions. The companys domain, prahavaccines.cz, facilitates information dissemination. Geographic operations remain based in the Czech Republic, serving regional and potential international needs.
Who are the top competitors of PRAHA VACCINES?
Who are PRAHA VACCINES's investors?
PRAHA VACCINES has 1 investor. Key investors include Novavax.